US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Merck & Co (NY:MRK)

144.30 +0.49 (+0.34%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stay informed with the top movers within the dow jones index on Monday. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Which dow jones stocks are moving on Thursday? ↗
Via Chartmill
Thursday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Merck (NYSE:MRK) Q2 Loss Narrows, Lifts Full-Year Sales Guidance ↗
Via Chartmill
News headline image
U.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk for Severe RSV for Their Second Season
From Merck & Co., Inc.
Via Business Wire
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
Merck & Co., Inc. Q2 Earnings Call Highlights ↗
Merck & Co., Inc. (NYSE:MRK) reported second-quarter revenue of $16.6 billion, up 5% from a year earlier, driven by oncology, animal health and contributions from newer product launches. Revenue... 
Via MarketBeat
Topics Earnings
S&P 500 Prints Fresh Record As Chips Rip And Hormuz Talks Crack The Oil Trade ↗
Via Chartmill
Topics Stocks
News headline image
MRK Q2 Deep Dive: Oncology and New Launches Drive Growth Amid Margin Compression
Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $16.61 billion. The c... 
Via StockStory
Which dow jones stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Merck (NYSE:MRK) Posts Better-Than-Expected Sales In Q2 CY2026
Global pharmaceutical company Merck (NYSE:MRK) announced better-than-expected revenue in Q2 CY2026, with sales up 5.1% year on year to $16.61 billion. The co... 
Via StockStory
News headline image
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
From Merck & Co., Inc.
Via Business Wire
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity ↗
Merck & Co., Inc. (NYSE:MRK) outlined its HIV treatment and prevention strategy at an investor event following the International AIDS Conference, highlighting Phase III results for a once-weekly oral... 
Via MarketBeat
Top dow jones movers in Monday's session ↗
Via Chartmill
News headline image
What To Expect From Merck’s (MRK) Q2 Earnings
Global pharmaceutical company Merck (NYSE:MRK) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Merck... 
Via StockStory
Top dow jones movers in Friday's session ↗
Via Chartmill
News headline image
1 Cash-Producing Stock with Promising Prospects and 2 That Underwhelm
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
Wednesday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
News headline image
Merck Announces Fourth-Quarter 2026 Dividend
From Merck & Co., Inc.
Via Business Wire
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Monday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗
There are plenty of reasons to love these companies. 
Via The Motley Fool
News headline image
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer ↗
Income seekers shouldn't give up on the stock yet. 
Via The Motley Fool
These dow jones stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >